Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To learn about the possible effects of a prebiotic food-enriched diet (PreFED) targeting the gut microbiome in participants with melanoma who are starting immune checkpoint blockade (ICB) therapy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18 years old

• Able to self-complete study assessments monitoring diet and gastrointestinal symptom burden

• Body mass index (BMI) 18.5-45 kg/m2

• ECOG performance status of 0 or 1

• Histologically confirmed stage III/IV, unresectable cutaneous, uveal, acral, or mucosal melanoma. Asymptomatic brain metastases are allowed.

• Planned initiation of 1st line standard-of-care approved immune checkpoint blockade (anti-PD1 +/- anti-CTLA4 or anti-LAG3 inhibitors) in the metastatic setting (prior ICB in adjuvant setting is allowed if last exposure ≥ 6 months prior). Prior targeted therapy is also allowed.

• Returning to MD Anderson for restaging and follow-up (ICB treatment may occur locally)

• WOCP must have negative UPT within 1 week of beginning dietary intervention.

• Self-reported willingness to eat the provided foods (with some tailoring to their food preferences)

• Self-reported willingness to comply with scheduled visits, undergo venipuncture, provide stool samples.

Locations
United States
Texas
MD Anderson Cancer Center
RECRUITING
Houston
Contact Information
Primary
Jennifer McQuade, MD
jmcquade@mdanderson.org
(713) 745-9947
Time Frame
Start Date: 2024-09-01
Estimated Completion Date: 2029-06-30
Participants
Target number of participants: 75
Treatments
Experimental: Prebiotic food-enriched diet (PreFED)
Participants will receive prebiotic food-enriched snacks and supportive nutritional counseling to increase prebiotic foods in the diet.
Related Therapeutic Areas
Sponsors
Leads: M.D. Anderson Cancer Center

This content was sourced from clinicaltrials.gov

Similar Clinical Trials